SCHEMBL8095765

SCHEMBL8095765

CCOC(=O)c1cccc(NC(=O)NC2CCCCNC2=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
RAB9A P51151 5/20 0.51
MAPT P10636 4/20 0.51
KMT2A Q03164 4/20 0.51
NPC1 O15118 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MEN1 O00255 2/20 0.51
NAMPT P43490 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GSK3B P49841 1/20 0.49
CSNK2A1 P68400 1/20 0.49
TSHR P16473 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
PKM P14618 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8093430 0.78 ALDH1A1 (0.62) ALDH1A1RAB9AKMT2ANPC1SMN1; SMN2
SCHEMBL10283456 0.76 MAPT (0.62) ALDH1A1RAB9AMAPTKMT2ANPC1
SCHEMBL803990 0.74 MAPT (0.61) ALDH1A1RAB9AMAPTKMT2ANPC1
SCHEMBL1641800 0.74 ALDH1A1 (0.79) ALDH1A1RAB9AMAPTKMT2ASMN1; SMN2
SCHEMBL6955644 0.73 ALDH1A1 (0.64) ALDH1A1RAB9AMAPTKMT2ANPC1
SCHEMBL24166922 0.73 RAB9A (0.70) ALDH1A1RAB9AMAPTKMT2ANPC1
SCHEMBL10212173 0.73 MAPT (0.56) ALDH1A1RAB9AMAPTKMT2ANPC1
SCHEMBL1640752 0.72 RAB9A (0.71) ALDH1A1RAB9AMAPTKMT2ANPC1
SCHEMBL4124085 0.72 MAPT (0.81) ALDH1A1RAB9AMAPTKMT2ANPC1
SCHEMBL8123409 0.71 KMT2A (0.68) ALDH1A1RAB9AMAPTKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6096885-A EXHIBIT AGONIST ACTIVITY FOR CCK-A RECEPTORS THEREBY ENABLING THEM TO MODULATE THE HORMONES GASTRIN AND CHOLECYSTOKININ IN MAMMALS. GLAXO WELLCOME INC. (US) 2000-08-01 US disclosed
EP-0785944-A1 ACYL AMINO ACETAMIDE DERIVATIVES WITH AGONIST ACTIVITY FOR CCK-A RECEPTORS GLAXO WELLCOME INC. (US) 1997-07-30 EP disclosed
WO-1996011940-A1 ACYL AMINO ACETAMIDE DERIVATIVES WITH AGONIST ACTIVITY FOR CCK-A RECEPTORS GLAXO WELLCOME INC. (US) 1996-04-25 WO disclosed